Peptide Lab HQ Research Guide
5-Amino-1MQ
A research-focused compound profile covering 5-Amino-1MQ identity, NNMT pathway research, concentration reference, reconstitution reference, and safety considerations.
Compound Data
Compound Profile
| Compound Name | 5-Amino-1MQ |
|---|---|
| Compound Type | Research compound |
| Research Category | NNMT and metabolic pathway research |
| Appearance | Lyophilized powder |
| Format | Research-use vial |
| Use | For laboratory research use only. |
Research Applications
Key Research Applications
5-Amino-1MQ is commonly studied in controlled research models involving nicotinamide N-methyltransferase activity, metabolic pathway regulation, adipocyte signaling, nicotinamide metabolism, and cellular energy-balance pathways.
NNMT Pathway Research
5-Amino-1MQ is commonly referenced in research involving nicotinamide N-methyltransferase, an enzyme associated with nicotinamide metabolism and cellular energy regulation.
Metabolic Pathway Models
Used in laboratory models exploring how NNMT-related pathways may influence metabolic signaling, substrate utilization, and cellular energy-balance mechanisms.
Adipocyte Research
Studied in models involving adipocyte behavior, fat-cell signaling, lipogenesis-related observations, and metabolic-response documentation.
Nicotinamide / NAD+ Research
Relevant to research exploring nicotinamide availability, NAD+-associated biochemical pathways, and cellular metabolic regulation.
Diet-Induced Obesity Models
Appears in preclinical research discussions involving diet-induced obesity, metabolic adaptation, and controlled animal research designs.
Cellular Energy Research
Used in research settings where investigators examine links between NNMT activity, cellular metabolism, and energy-balance observations.
Research Scope
These applications are provided for educational and research-reference purposes only. Research outcomes may vary based on model type, salt form, study design, purity, concentration, and laboratory conditions.
Reference Only
Reconstitution / Research Dosing Reference
Select Reference Vial
Select a vial size to update the concentration, U-100 unit references, and frequency table below.
Quick Reference Summary
| Reference Vial | 5 mg 5-Amino-1MQ |
|---|---|
| Primary Solution Volume | 2.0 mL bacteriostatic water |
| Primary Concentration | 2.5 mg/mL |
| Measurement Reference | On a U-100 syringe, 1 unit = 0.01 mL. |
| Amount per U-100 Unit | At 2.5 mg/mL, 1 unit equals 0.025 mg / 25 mcg 5-Amino-1MQ. |
| Storage Reference | Refrigerate at 2–8°C / 35.6–46.4°F after preparation, protected from direct light, unless supplier documentation specifies otherwise. |
Reconstitution Steps
- Draw 2.0 mL bacteriostatic water using a sterile syringe for the main concentration reference shown below.
- Slowly add the BAC water down the side of the vial wall.
- Gently roll or swirl the vial until the material is completely dissolved. The solution should appear clear to slightly hazy depending on concentration and supplier format. Do not shake!
- Because 5-Amino-1MQ is commonly referenced as a small-molecule NNMT inhibitor rather than a standard peptide, verify solvent compatibility, solubility, and handling notes against the supplier COA, batch record, or formula record when available.
- Label with compound name, vial amount, concentration, solvent volume, preparation date, storage conditions, and handling notes.
- Store refrigerated at 2–8°C / 35.6–46.4°F, protected from direct light, unless supplier documentation specifies otherwise.
Published Research Context
| Reference Type | Reported Amount / Context | Research Notes |
|---|---|---|
| Compound Identity Reference | 5-Amino-1MQ, commonly referenced as 5-amino-1-methylquinolinium | 5-Amino-1MQ is commonly discussed as a synthetic small-molecule NNMT inhibitor in metabolic, adipose-tissue, and energy-homeostasis research contexts. |
| NNMT Inhibition Research | Nicotinamide N-methyltransferase pathway context | Commonly discussed in NNMT activity, NAD+ metabolism, methylation-related pathway context, SAM availability, and metabolic-regulation research models. |
| Adiposity / Metabolic Research Context | Preclinical and model-dependent context | 5-Amino-1MQ has been discussed in diet-induced obesity, adiposity, body-weight marker, adipose-tissue, and metabolic-disease research models. |
| NAD+ / SAM Research Context | Model-dependent metabolic-marker tracking | NNMT inhibition research commonly includes NAD+ availability, SAM-associated methylation context, mitochondrial-function markers, and cellular energy-metabolism observations. |
| Muscle / Regeneration Research Context | Preclinical aged-muscle and regenerative-capacity context | NNMT inhibitor research has appeared in aged-muscle, strength, regenerative-capacity, tissue-repair, and metabolic-function research discussions. |
| Analytical Method Reference | LC-MS/MS assay context | Published analytical work has discussed measurement methods for 5-amino-1-methylquinolinium in pharmacokinetic and research-assay contexts. |
| Public Protocol-Style Reference | Milligram-range reference examples | Public protocol-style references may describe 5-Amino-1MQ in milligram-range examples depending on the research model and preparation format. These are not clinical dosing standards. |
| Clinical / Research-Chemical Status | No universal research-chemical protocol established | Published study references, preclinical model references, public protocol-style references, or wellness protocols should not be treated as dosing instructions for research-chemical vial formats. |
Concentration Reference
| Vial Amount | Solution Volume | Final Concentration |
|---|---|---|
| 5 mg | 2.0 mL | 2.5 mg/mL |
| 10 mg | 2.0 mL | 5 mg/mL |
| 50 mg | 3.0 mL | 16.67 mg/mL |
Research Dosing Amount / Volume Reference
| Reference Amount | Volume at 2.5 mg/mL | U-100 Unit Reference | Approx. References per 5 mg Vial |
|---|---|---|---|
| 0.1 mg / 100 mcg | 0.04 mL | 4 units | 50 |
| 0.25 mg / 250 mcg | 0.10 mL | 10 units | 20 |
| 0.5 mg / 500 mcg | 0.20 mL | 20 units | 10 |
| 1 mg / 1000 mcg | 0.40 mL | 40 units | 5 |
| 2 mg / 2000 mcg | 0.80 mL | 80 units | 2.5 |
| 5 mg / 5000 mcg | 2.00 mL | 200 units | 1 |
| 10 mg / 10000 mcg | 4.00 mL | 400 units | 0.5 |
| 25 mg / 25000 mcg | 10.00 mL | 1000 units | 0.2 |
| 50 mg / 50000 mcg | 20.00 mL | 2000 units | 0.1 |
Research Frequency / Amount Reference
| Research Window | Frequency | Reference Amount | Units / Volume Reference |
|---|---|---|---|
| Lower Conversion Reference | Calculation reference only | 0.1 mg reference amount | 4 units / 0.04 mL |
| Low Conversion Reference | Public protocol-style reference, not a clinical dosing standard | 250 mcg reference amount | 10 units / 0.10 mL |
| Low-to-Mid Conversion Example | Public protocol-style reference, not a clinical dosing standard | 0.5 mg reference amount | 20 units / 0.20 mL |
| Mid-Range Conversion Example | Calculation reference only | 1 mg reference amount | 40 units / 0.40 mL |
| Upper Conversion Example | Calculation reference only | 2 mg reference amount | 80 units / 0.80 mL |
| 5 mg Preparation Reference | Preparation-level calculation reference | 5 mg reference amount | 200 units / 2.00 mL |
| 10 mg Preparation Reference | Preparation-level calculation reference | 10 mg reference amount | 400 units / 4.00 mL |
| High Conversion Example | Calculation reference only | 25 mg reference amount | 1000 units / 10.00 mL |
| 50 mg Preparation Reference | Preparation-level calculation reference | 50 mg reference amount | 2000 units / 20.00 mL |
Common Research Windows
| Reference Window | Common Length | Research Notes |
|---|---|---|
| Cell-Culture / NNMT Marker Window | 24–72 hours | May be used for NNMT activity, NAD+ marker, SAM marker, methylation-associated pathway, adipocyte-response, or cellular energy-marker documentation depending on the model. |
| Acute Metabolic Observation Window | Single session to several days | Used for short-term metabolic-marker comparison, adipose-tissue response tracking, NAD+ / SAM observation, or early pathway documentation depending on the research design. |
| Short Research Window | 1–4 weeks | May be used for early controlled observation involving adiposity markers, energy-metabolism markers, mitochondrial-function markers, or diet-intervention model endpoints. |
| Standard Protocol-Style Window | 4–8 weeks | Commonly used in public protocol-style references for structured observation and comparison across baseline and follow-up periods. |
| Extended Observation Window | 8–12 weeks or longer | Used when longer documentation is needed for body-composition markers, adipose-tissue trends, muscle-regeneration context, metabolic-marker comparison, or follow-up marker tracking. |
| Follow-Up / Washout | 2–8 weeks | Used to document post-study observations, marker return, delayed response patterns, or follow-up data depending on the research model. |
Research Note: These tables are provided for educational, research-planning, concentration, frequency-reference, and volume-reference purposes only. 5-Amino-1MQ, commonly referenced as 5-amino-1-methylquinolinium, is discussed in NNMT inhibitor, NAD+ metabolism, SAM-associated methylation context, adipose-tissue, adiposity, metabolic-marker, diet-induced obesity, energy-homeostasis, mitochondrial-function, and muscle-regeneration research contexts. The selector above updates calculations for 5 mg and 10 mg vial references reconstituted with 2.0 mL bacteriostatic water, and a 50 mg vial reference reconstituted with 3.0 mL bacteriostatic water. Because 5-Amino-1MQ is commonly referenced as a small-molecule research compound rather than a standard peptide, solvent compatibility and solubility should be verified against the supplier COA, batch record, or formula record when available. Published study references, preclinical model references, and public protocol-style frequency references are not universal research-chemical dosing standards and should not be treated as dosing instructions for research-chemical vial formats. This information is not medical advice, dosing instruction, injectable-use guidance, or a recommendation for human or animal use.
Research Notes
Research Findings & Safety Notes
Research Findings
Research discussions around 5-Amino-1MQ commonly focus on NNMT activity, cellular metabolism, and metabolic pathway modeling.
Study Limitations
Findings may vary based on model type, study design, concentration, purity, and laboratory conditions.
Safety Considerations
This material should be handled only in appropriate laboratory settings using proper PPE and qualified procedures.
Use Restriction
Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.
Related Supplies
Research Supplies
For research supplies, visit our affiliate partner and use code PLHQ10 to save 10% on your order.
Bacteriostatic Water
Commonly referenced in laboratory preparation workflows.
Research Syringes
Supply category for controlled laboratory research preparation.
Prep Supplies
Supporting supplies for clean handling, preparation, and documentation.
Lab Handling
Handling & Storage
Storage
Store materials according to product-specific requirements. Protect from excessive heat, moisture, and direct light.
After Reconstitution
Keep refrigerated after reconstitution unless otherwise specified by the product documentation.
Handling
Use appropriate laboratory PPE, clean handling practices, and qualified research procedures.
Documentation
Maintain batch details, COA records, preparation notes, and internal research documentation.